8-K current report · filed Mar 2, 2026

Elevance Health (ELV) 8-K Current Report: March 2, 2026

Item 8.01ELV overview

Short answer

Elevance Health (ELV) filed an 8-K current report with the SEC on March 2, 2026 reporting Item 8.01 (Other Events). CMS notifying intent to suspend new Medicare Advantage enrollment into ELV's MA-PD plans effective March 31, 2026: a direct hit to growth pipeline.

Elevance Health 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • CMS notifying intent to suspend new Medicare Advantage enrollment into ELV's MA-PD plans effective March 31, 2026: a direct hit to growth pipeline
  • Sanctions tied to risk adjustment data submission noncompliance for dates of service prior to April 3, 2023; ELV revised practices in April 2023 following new CMS guidance
  • Enrollment suspension would block new member acquisition in MA-PD during a critical selling season, pressuring future Medicare revenue growth
  • Current MA-PD members' benefits unaffected: no immediate membership loss, but reputational and regulatory overhang is material
  • Sanctions lifted only if CMS determines issues satisfactorily resolved before March 31: outcome and timeline uncertain, adding regulatory risk to 2026 guidance

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Elevance Health 8-K filings

Get the next ELV 8-K as it lands

Follow ELV for push alerts, or ask the research agent what this filing means.